(Q32097605)

6 July 2017

Effect of concurrent anxiety on response to sertraline and imipramine in patients with chronic depression (English)

1 reference

ORCID Public Data File 2021

6 July 2017

1 reference

1 reference

author name string

J M Russell

1

1 reference

6 July 2017

L M Koran

2

1 reference

6 July 2017

J Rush

3

1 reference

6 July 2017

R M Hirschfeld

4

1 reference

6 July 2017

W Harrison

5

1 reference

6 July 2017

E S Friedman

6

1 reference

6 July 2017

S Davis

7

1 reference

6 July 2017

M Keller

8

1 reference

6 July 2017

1 January 2001

1 reference

6 July 2017

Depression and Anxiety

1 reference

6 July 2017

13

1 reference

6 July 2017

1

1 reference

6 July 2017

18-27

1 reference

Follow-up and family study of anxious depression

6 July 2017

1 reference

https://api.crossref.org/works/10.1002%2F1520-6394%282001%2913%3A1%3C18%3A%3AAID-DA3%3E3.0.CO%3B2-M

Major depressive subtypes and treatment response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-6394%282001%2913%3A1%3C18%3A%3AAID-DA3%3E3.0.CO%3B2-M

Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-6394%282001%2913%3A1%3C18%3A%3AAID-DA3%3E3.0.CO%3B2-M

A rating scale for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-6394%282001%2913%3A1%3C18%3A%3AAID-DA3%3E3.0.CO%3B2-M

Anxiety and depression in a community sample: the influence of comorbidity on social functioning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-6394%282001%2913%3A1%3C18%3A%3AAID-DA3%3E3.0.CO%3B2-M

Prevalence and comorbidity of dysthymic disorder among psychiatric outpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-6394%282001%2913%3A1%3C18%3A%3AAID-DA3%3E3.0.CO%3B2-M

A double-blind comparison of sertraline and clomipramine in the treatment of major depressive disorder and associated anxiety in general practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-6394%282001%2913%3A1%3C18%3A%3AAID-DA3%3E3.0.CO%3B2-M

Sertraline in the treatment of panic disorder: a double-blind multicenter trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-6394%282001%2913%3A1%3C18%3A%3AAID-DA3%3E3.0.CO%3B2-M

Sertraline in the treatment of panic disorder: a flexible-dose multicenter trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-6394%282001%2913%3A1%3C18%3A%3AAID-DA3%3E3.0.CO%3B2-M

A meta-analysis of the effects of venlafaxine on anxiety associated with depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-6394%282001%2913%3A1%3C18%3A%3AAID-DA3%3E3.0.CO%3B2-M

Syndrome comorbidity in patients with major depression or dysthymia: prevalence and temporal relationships

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-6394%282001%2913%3A1%3C18%3A%3AAID-DA3%3E3.0.CO%3B2-M

The Prognosis of Affective Disorders: the Differentiation of Anxiety States from Depressive Illnesses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-6394%282001%2913%3A1%3C18%3A%3AAID-DA3%3E3.0.CO%3B2-M

Short-term augmentation of fluoxetine with clonazepam in the treatment of depression: a double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-6394%282001%2913%3A1%3C18%3A%3AAID-DA3%3E3.0.CO%3B2-M

Anxious depressions. Clinical, family history, and naturalistic outcome--comparisons with panic and major depressive disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-6394%282001%2913%3A1%3C18%3A%3AAID-DA3%3E3.0.CO%3B2-M

Outcome of panic and depression in a seven-year follow-up: results of the Zurich study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-6394%282001%2913%3A1%3C18%3A%3AAID-DA3%3E3.0.CO%3B2-M

The epidemiology of dysthymia in five communities: rates, risks, comorbidity, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-6394%282001%2913%3A1%3C18%3A%3AAID-DA3%3E3.0.CO%3B2-M

10.1002/1520-6394(2001)13:1<18::AID-DA3>3.0.CO;2-M

21 January 2018

Identifiers

DOI

1 reference

6 July 2017

1 reference